共 573 条
[11]
Brück W(2006)Interferon beta-1a treatment in childhood and juvenile-onset multiple sclerosis Neurology. 67 511-513
[12]
Chitnis T(2005)Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a Neurology. 64 888-890
[13]
Steinbrook R(2003)Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis Neuropediatrics. 34 120-126
[14]
Chitnis T(2017)Bringing the HEET: the argument for high-efficacy early treatment for pediatric-onset multiple sclerosis Neurotherapeutics 14 985-998
[15]
Ghezzi A(2019)Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis JAMA 321 175-187
[16]
Krysko KM(2014)Disease activity free status: a new end point for a new era in multiple sclerosis clinical research? JAMA Neurol. 71 269-270
[17]
Graves J(2009)Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis Arch Neurol 66 54-59
[18]
Rensel M(2014)Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years Mult Scler Relat Disord. 3 186-193
[19]
Weinstock-Guttman B(2013)Long-term outcome of paediatric-onset multiple sclerosis: a population-based study J Neurol Neurosurg Psychiatry 84 141-147
[20]
Aaen G(2010)Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up Neurology. 75 1134-1140